≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Nonhereditary hypogammaglobulinemia

DOID EFO Endpoint Browser PheWeb

D3_NONHEREDHYPOGAMMA

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D80.1
  • Cause of death: ICD-10 — D80.1

2 out of 7 registries used, show all original rules.

375

4. Check minimum number of events

None

375

5. Include endpoints

None

375

6. Filter based on genotype QC (FinnGen only)

375

Control definitions (FinnGen only)

Control exclude
D3_IMMUNEMECHANISM

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D80
Name in latin
Hypogammaglobulinaemia non familialis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1373 825 543
Only index persons 1282 786 496
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.02
Only index persons 0.03 0.03 0.02
Median age at first event (years)
Whole population 50.05 52.53 46.32
Only index persons 49.45 52.05 45.35

-FinnGen-

Key figures

All Female Male
Number of individuals 375 246 129
Unadjusted period prevalence (%) 0.07 0.08 0.06
Median age at first event (years) 51.28 50.81 52.19

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
333
Matched controls
3328
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
323.0
328
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
181.3
157
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
177.4
154
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
96.7
88
*
ZX120
NOMESCO Finland
Intravenous
19.2
88.7
146
130
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
85.1
78
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
80.6
74
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
24.9
78.4
114
68
J18.9
ICD-10 Finland
Pneumonia, unspecified
10.8
77.9
185
346
J01MA14
ATC
moxifloxacin; systemic
16.8
74.1
127
118
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
24.1
73.6
108
65
J01MA12
ATC
levofloxacin; systemic
9.5
69.8
177
354
6BA02
NOMESCO Finland
NA
273.2
66.9
66
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
8.0
65.6
244
851
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
14.5
65.4
119
123
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
64.7
60
*
H02AB06
ATC
prednisolone; systemic
8.2
63.0
265
1073
WW200
NOMESCO Finland
Immunization
39.6
61.2
77
25
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
14.2
58.4
106
106
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
20.3
55.9
86
56
J47
ICD-10 Finland
Bronchiectasis
38.2
55.2
70
23
TPH04
NOMESCO Finland
Cathetrisation of vein
7.3
54.1
162
382
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
26.1
49.1
69
33
TDM10
NOMESCO Finland
Puncture of maxillary antrum
16.4
47.4
79
62
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
13.6
46.7
85
82
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.7
46.4
182
578
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
21.4
46.2
69
40
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.6
44.5
119
227
H02AB07
ATC
prednisone; oral
7.1
41.6
117
237
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
41.5
39
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
5.4
41.1
162
499
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
449.2
41.0
40
*
R50.9
ICD-10 Finland
Fever, unspecified
6.7
40.7
120
258
A49.9
ICD-10 Finland
Bacterial infection, unspecified
9.2
39.8
90
129
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
10.2
39.0
82
103
UGC12
NOMESCO Finland
Flexible bronchoscopy
11.4
38.7
76
84
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.8
38.0
180
659
C01CA24
ATC
epinephrine; parenteral
8.9
36.6
84
122
J45.1
ICD-10 Finland
Nonallergic asthma
9.5
36.6
80
107
H02AB09
ATC
hydrocortisone; systemic
25.9
36.6
51
23
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
5.6
34.9
121
310
TGC00
NOMESCO Finland
Bronchial lavation
24.6
33.3
47
22
J01FA06
ATC
roxithromycin; oral
4.1
32.3
210
981
Z01.8
ICD-10 Finland
Other specified special examinations
4.5
31.5
139
453
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
9.3
30.3
66
86
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
29.6
28
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
9.0
29.4
65
87
J01MA02
ATC
ciprofloxacin; systemic
3.8
29.3
183
802
R03BB04
ATC
tiotropium bromide; inhalant
7.3
28.5
73
123
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.8
28.0
242
1365
J45.9
ICD-10 Finland
Asthma, unspecified
4.5
27.5
115
347
L03AA02
ATC
filgrastim; parenteral
15.1
27.4
46
35
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.4
27.2
119
374
C03CA01
ATC
furosemide; systemic
4.4
26.9
117
365
J05AB11
ATC
valaciclovir; oral
5.2
26.9
94
234
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
65.6
26.4
30
5
R03AK06
ATC
salmeterol and fluticasone; inhalant
5.2
26.2
92
229
J45.0
ICD-10 Finland
Predominantly allergic asthma
6.2
26.2
76
151
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
3.5
26.1
217
1155
XW000
NOMESCO Finland
Bone marrow biopsy
12.5
25.3
46
42
JN4BD
NOMESCO Finland
Extensive body CT
6.1
25.0
74
150
M05BA04
ATC
alendronic acid; oral
7.2
24.7
63
104
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.4
24.6
56
78
J32.4
ICD-10 Finland
Chronic pansinusitis
25.1
24.4
34
15
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
60.9
24.4
28
5
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
9.2
23.8
51
64
J01FA10
ATC
azithromycin; systemic
3.6
23.6
255
1595
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.5
23.6
147
611
N02AX02
ATC
tramadol; systemic, rectal
3.3
23.3
180
878
J46
ICD-10 Finland
Status asthmaticus
14.6
23.1
39
30
R03BA02
ATC
budesonide; inhalant
4.0
22.7
106
345
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
18.8
22.3
34
20
ZX108
NOMESCO Finland
Inhalation
67.3
22.2
25
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.8
22.0
66
135
ZXA10
NOMESCO Finland
Bilateral
4.0
21.9
104
343
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.4
21.6
60
111
J45.8
ICD-10 Finland
Mixed asthma
13.7
21.4
37
30
Z3231
NOMESCO Finland
Registered nurse
3.4
21.3
134
550
A07AA02
ATC
nystatin; oral
6.9
21.1
55
93
R03DC03
ATC
montelukast; oral
3.9
21.0
100
329
UJF32
NOMESCO Finland
Coloscopy
3.4
20.8
127
509
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.7
20.8
63
130
R03BB01
ATC
ipratropium bromide; inhalant
11.5
20.8
39
38
GD1AD
NOMESCO Finland
Thorax CT examination
8.7
20.4
45
59
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
8.7
20.1
44
57
J01FA15
ATC
telithromycin; oral
4.7
20.1
75
195
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
20.0
19
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
31.2
20.0
26
9
A03FA01
ATC
metoclopramide; systemic, rectal
3.6
19.9
108
393
R03AC02
ATC
salbutamol; inhalant
3.0
19.5
222
1342
R03AC12
ATC
salmeterol; inhalant
9.2
19.4
41
50
J01FF01
ATC
clindamycin; systemic
3.1
19.3
140
627
M04AA01
ATC
allopurinol; systemic
5.1
19.3
65
151
R03DA04
ATC
theophylline; systemic, rectal
8.1
19.3
44
61
ZX121
NOMESCO Finland
Central venous catheter
+∞
18.9
18
*
XG410
NOMESCO Finland
Flow-volume spirometry
9.1
18.9
40
49
J01AA02
ATC
doxycycline; systemic
3.7
18.1
289
2140
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
70.6
17.9
20
*
GD1DG
NOMESCO Finland
Extremely extensive MRI examination of pleura with high field magnet
+∞
17.9
17
*
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
+∞
17.9
17
*
WZC30
NOMESCO Finland
Teaching
4.1
17.7
77
230
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.0
17.6
77
231
A46
ICD-10 Finland
Erysipelas
4.2
17.5
73
210
N02AA05
ATC
oxycodone; systemic
4.2
17.3
72
206
L04AX01
ATC
azathioprine; systemic
7.8
17.2
40
57
D83.8
ICD-10 Finland
Other common variable immunodeficiencies
+∞
16.8
16
*
SPAT1262
SPAT
Handing over of treatment supplies
3.5
16.8
90
319
TAB00
NOMESCO Finland
Lumbar puncture
7.3
16.8
41
63
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
21.4
16.7
24
12
A41.9
ICD-10 Finland
Sepsis, unspecified
9.3
16.4
34
40
J02AC01
ATC
fluconazole; systemic
2.6
16.1
183
1051
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.3
16.1
30
29
J01DA08
ATC
[U] cefaclor; oral
4.1
16.0
68
198
R01AD09
ATC
mometasone; nasal
2.6
15.9
194
1156
R01AD08
ATC
fluticasone; nasal
2.8
15.9
140
689
A02BC02
ATC
pantoprazole; systemic
2.8
15.9
243
1647
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
63.2
15.9
18
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
27.9
15.8
21
8
ZXD05
NOMESCO Finland
Urgent procedure
2.8
15.7
133
639
R06AE07
ATC
cetirizine; oral
2.6
15.5
184
1076
ZXE20
NOMESCO Finland
More than three and less than five hours
3.9
15.5
69
209
UJF30
NOMESCO Finland
Ileoscopy through colon
4.4
15.3
59
156
J01FA09
ATC
clarithromycin; systemic
2.7
15.2
146
755
JN4AD
NOMESCO Finland
Body CT examination
5.4
15.1
47
99
Z3226
NOMESCO Finland
Physiotherapist
3.2
14.9
89
338
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
19.5
14.9
22
12
H02AB04
ATC
methylprednisolone; systemic
3.4
14.8
79
276
GD1CG
NOMESCO Finland
Extensive examination of lungs and pleura with high intensity magnet
+∞
14.7
14
*
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
9.3
14.6
30
35
D70.89
ICD-10 Finland
Neutropenic splenomegaly
28.7
14.4
19
7
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.2
14.4
89
345
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
6.0
14.3
40
74
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
10.1
14.3
28
30
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
44.6
14.2
17
*
A41.8
ICD-10 Finland
Other specified sepsis
16.7
14.1
22
14
Z2221
NOMESCO Finland
Medical doctor
2.7
14.1
123
596
R06.0
ICD-10 Finland
Dyspnoea
2.9
14.0
100
427
R03BA05
ATC
fluticasone; inhalant
3.0
14.0
94
385
A07AA09
ATC
vancomycin; oral
21.2
14.0
20
10
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
21.2
14.0
20
10
WW500
NOMESCO Finland
Blood transfusion
7.0
13.8
34
53
L03AA13
ATC
pegfilgrastim; parenteral
7.6
13.7
32
46
J01DA06
ATC
[U] cefuroxime; systemic
3.3
13.7
78
284
D80.6
ICD-10 Finland
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
+∞
13.6
13
*
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
+∞
13.6
13
*
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
13.6
13
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
13.6
13.6
23
18
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
145.7
13.5
14
*
J01DB01
ATC
cefalexin; oral
3.2
13.4
294
2330
XF400
NOMESCO Finland
ECG with 12 standard connections
3.3
13.3
74
266
WX892
NOMESCO Finland
Monitored bed care
4.8
13.2
45
105
H04.10
ICD-10 Finland
Dry eye syndrome
3.8
13.2
60
184
R4110
NOMESCO Finland
Physiotherapy
2.7
13.1
112
533
R03AK08
ATC
formoterol and beclometasone; inhalant
7.0
13.0
32
50
ZXA00
NOMESCO Finland
Right side
2.7
12.9
111
528
H65.2
ICD-10 Finland
Chronic serous otitis media
16.3
12.8
20
13
1XC02
NOMESCO Finland
NA
33.5
12.7
16
5
R03BA08
ATC
ciclesonide; inhalant
4.0
12.7
53
151
J31.0
ICD-10 Finland
Chronic rhinitis
4.2
12.6
49
130
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
25.5
12.6
17
7
J06BA02
ATC
immunoglobulins, normal human, for intravascular adm.; systemic
+∞
12.6
12
*
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
+∞
12.6
12
*
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
12.6
12
*
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
134.9
12.5
13
*
A01AB09
ATC
miconazole; local oral
3.8
12.5
55
164
R01AD05
ATC
budesonide; nasal
4.1
12.4
50
138
B29
ICPC
Lymph/immune mech sympt/complt other
39.1
12.3
15
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
27.9
12.2
16
6
TQW99
NOMESCO Finland
Other minor procedure on skin
6.6
12.2
31
51
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
12.0
60
198
R03AC13
ATC
formoterol; inhalant
5.7
11.9
34
65
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.2
11.8
66
237
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
17.2
11.8
18
11
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
13.2
11.8
20
16
ZXE00
NOMESCO Finland
One hour or less
2.3
11.7
152
886
L01BB05
ATC
fludarabine; systemic
67.4
11.7
13
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.8
11.7
51
151
D70.82
ICD-10 Finland
Drug-induced neutropenia
14.3
11.6
19
14
N03AX16
ATC
pregabalin; oral
2.6
11.4
96
445
L04AA06
ATC
mycophenolic acid; systemic
11.1
11.4
21
20
R03AC03
ATC
terbutaline; inhalant
3.1
11.3
67
250
ZYC01
NOMESCO Finland
Remote contact by phone
5.2
11.3
35
74
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
11.2
111
561
SPAT1255
SPAT
Intravenous administration of medicine
4.6
11.2
39
93
N03AX12
ATC
gabapentin; oral
3.0
11.1
69
264
J01.1
ICD-10 Finland
Acute frontal sinusitis
14.6
11.1
18
13
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.3
11.1
24
31
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.4
11.0
55
181
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.1
11.0
63
230
C10AC01
ATC
colestyramine; oral
9.3
10.9
22
25
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
11.1
10.9
20
19
ZXA05
NOMESCO Finland
Left side
2.5
10.9
100
486
R03DC01
ATC
zafirlukast; oral
10.1
10.9
21
22
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
29.1
10.8
14
5
N05CF01
ATC
zopiclone; oral
2.4
10.7
116
614
R81
ICPC
Pneumonia
6.3
10.7
28
48
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
62.0
10.7
12
*
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
62.0
10.7
12
*
R05
ICD-10 Finland
Cough
2.7
10.6
84
374
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.4
10.6
38
94
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.6
10.5
49
153
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
113.4
10.5
11
*
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
113.4
10.5
11
*
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
+∞
10.5
10
*
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
7.9
10.4
23
31
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
7.9
10.4
23
31
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.1
10.4
40
106
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.0
10.3
33
72
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.6
10.3
87
402
J05AB01
ATC
aciclovir; systemic
2.5
10.3
92
440
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
13.7
10.3
17
13
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.4
10.2
37
92
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
15.2
10.1
16
11
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
15.2
10.1
16
11
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.7
10.0
45
136
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
41.4
10.0
12
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
41.4
10.0
12
*
J01.4
ICD-10 Finland
Acute pansinusitis
17.4
10.0
15
9
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
6.2
9.9
26
45
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
26.9
9.9
13
5
A02BC05
ATC
esomeprazole; systemic
2.1
9.9
155
964
A28
ICPC
Limited function/disability NOS
3.3
9.8
51
173
ZX114
NOMESCO Finland
Intramuscular
13.9
9.8
16
12
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.0
9.7
59
223
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.3
9.7
50
169
I50.9
ICD-10 Finland
Heart failure, unspecified
4.0
9.6
39
108
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
15.6
9.6
15
10
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.6
9.6
43
130
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.1
9.6
37
98
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.5
9.6
24
39
J01DA01
ATC
[U] cefalexin; systemic
2.1
9.6
225
1648
A04AA01
ATC
ondansetron; systemic, rectal
3.8
9.6
40
114
A02BC01
ATC
omeprazole; systemic
2.3
9.5
105
555
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
8.4
9.5
20
25
L01XE27
ATC
[U] ibrutinib; oral
102.8
9.5
10
*
390
Kela drug reimbursment
Ibrutinib
102.8
9.5
10
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.5
9.4
80
369
D81.0
ICD-10 Finland
Severe combined immunodeficiency [SCID] with reticular dysgenesis
+∞
9.4
9
*
D84.1
ICD-10 Finland
Defects in the complement system
+∞
9.4
9
*
S97
ICPC
Chronic ulcer skin
6.1
9.4
25
44
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
11.1
9.4
17
16
D64.9
ICD-10 Finland
Anaemia, unspecified
3.5
9.3
43
134
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.2
9.2
24
41
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.8
9.2
64
264
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.9
9.1
37
103
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.1
9.1
28
59
J32.8
ICD-10 Finland
Other chronic sinusitis
37.8
9.1
11
*
B01AB05
ATC
enoxaparin; parenteral
2.2
9.0
109
597
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.6
9.0
73
329
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.0
8.9
54
203
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
8.9
133
798
Z2446
NOMESCO Finland
Social worker
3.9
8.9
36
100
B99
ICD-10 Finland
Other and unspecified infectious diseases
9.9
8.9
17
18
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
4.9
8.8
28
61
JN3AD
NOMESCO Finland
Abdominal CT examination
3.6
8.8
39
117
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
8.8
128
761
R03AK07
ATC
formoterol and budesonide; inhalant
2.4
8.8
85
419
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.2
8.8
114
646
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.6
8.7
39
118
A07EA06
ATC
budesonide; oral, local oral
5.4
8.7
25
49
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
5.4
8.7
25
49
N02BE01
ATC
paracetamol; systemic, rectal
2.6
8.7
293
2461
A04AA02
ATC
granisetron; systemic, transdermal
4.0
8.7
34
92
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.1
8.6
49
178
XQ800
NOMESCO Finland
Prick test
3.4
8.5
42
137
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
28.3
8.5
11
*
318
Kela drug reimbursment
Teriparatide
28.3
8.5
11
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.3
8.5
25
50
A01AB04
ATC
amphotericin B; local oral
4.3
8.5
31
78
E0000UV
ATC
NA
2.0
8.5
149
953
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
8.5
146
924
J20
ICD-10 Finland
Acute bronchitis
3.2
8.5
45
155
Z3229
NOMESCO Finland
Other healthcare associate professional
3.5
8.5
40
126
R1250
NOMESCO Finland
Evaluation of functional capability
8.2
8.5
18
23
UDM02
NOMESCO Finland
Sinoscopy
6.5
8.5
21
34
K90.0
ICD-10 Finland
Coeliac disease
6.5
8.5
21
34
ZX110
NOMESCO Finland
Intracutaneous
92.3
8.5
9
*
1512
Kela drug reimbursment
Ibrutinib
92.3
8.5
9
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.6
8.4
38
116
J33.8
ICD-10 Finland
Other polyp of sinus
8.9
8.4
17
20
R01AD12
ATC
fluticasone furoate; nasal
2.1
8.4
124
739
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
9.8
8.4
16
17
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
+∞
8.4
8
*
D81.1
ICD-10 Finland
Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
+∞
8.4
8
*
2790C
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI ALIA]
+∞
8.4
8
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
8.3
64
280
ZXD20
NOMESCO Finland
Day surgery
2.8
8.2
57
232
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.1
8.2
46
164
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.5
8.2
71
331
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
12.1
8.1
14
12
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
12.1
8.1
14
12
P01AB01
ATC
metronidazole; oral, rectal
2.0
8.1
154
1008
B28
ICPC
Limited function/disability (B)
34.3
8.1
10
*
L01AA01
ATC
cyclophosphamide; systemic
34.3
8.1
10
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.5
8.1
70
325
A06AD11
ATC
lactulose; oral
2.8
8.1
53
209
ZX112
NOMESCO Finland
Subcutaneous
7.5
8.1
18
25
XA800
NOMESCO Finland
Neuropsychological investigation
4.6
8.0
27
63
XG466
NOMESCO Finland
Sleep oxymetry
5.7
8.0
22
41
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.5
8.0
36
110
M05BX04
ATC
denosumab; parenteral
4.7
8.0
26
59
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.1
7.9
24
50
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.6
7.9
35
105
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
8.8
7.9
16
19
212
Kela drug reimbursment
Gout
11.2
7.9
14
13
J01DC04
ATC
cefaclor; oral
9.8
7.9
15
16
C03DA01
ATC
spironolactone; oral
3.3
7.8
39
129
J32.1
ICD-10 Finland
Chronic frontal sinusitis
46.1
7.7
9
*
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
46.1
7.7
9
*
M81.9
ICD-10 Finland
Osteoporosis, unspecified
5.4
7.7
22
43
D07AB08
ATC
desonide; topical
3.1
7.7
43
153
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
8.3
7.7
16
20
N05CD07
ATC
temazepam; oral
2.8
7.7
49
192
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
12.2
7.6
13
11
H05AA02
ATC
teriparatide; parenteral
25.7
7.6
10
*
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
10.4
7.6
14
14
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
10.4
7.6
14
14
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.3
7.6
27
67
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.3
7.6
22
44
N17.9
ICD-10 Finland
Acute renal failure, unspecified
6.2
7.5
19
32
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.2
7.5
19
32
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
7.5
46
174
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
81.8
7.4
8
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
81.8
7.4
8
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
81.8
7.4
8
*
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
81.8
7.4
8
*
R06AE09
ATC
levocetirizine; oral
2.4
7.4
68
322
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.0
7.4
42
151
E86
ICD-10 Finland
Volume depletion
9.7
7.4
14
15
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
9.7
7.4
14
15
E87.6
ICD-10 Finland
Hypokalaemia
5.7
7.3
20
37
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
7.3
7
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
+∞
7.3
7
*
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
+∞
7.3
7
*
4AA24
NOMESCO Finland
NA
+∞
7.3
7
*
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
7.3
7
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.6
7.3
53
224
JN6AD
NOMESCO Finland
CT of torso and neck
16.2
7.3
11
7
P01BA02
ATC
hydroxychloroquine; oral
3.0
7.2
41
148
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
6.8
7.2
17
26
UDC00
NOMESCO Finland
Ear microscopy
3.3
7.2
35
114
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.3
7.2
35
114
D07AA02
ATC
hydrocortisone; topical
2.5
7.2
60
273
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
30.7
7.2
9
*
DPA30
NOMESCO Finland
Sphenotomy
30.7
7.2
9
*
X57
ICD-10 Finland
Unspecified privation
6.3
7.2
18
30
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.3
7.2
25
61
R03AK11
ATC
formoterol and fluticasone; inhalant
4.9
7.2
22
47
J01DC02
ATC
cefuroxime; systemic
3.6
7.2
31
92
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
7.1
45
174
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
12.4
7.1
12
10
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.7
7.1
48
194
L28
ICPC
Limited function/disability (L)
2.6
7.1
54
234
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
5.4
7.1
20
39
A02BC03
ATC
lansoprazole; oral
2.0
7.0
107
634
N03AX11
ATC
topiramate; oral
5.7
7.0
19
35
J01CA04
ATC
amoxicillin; systemic
2.2
7.0
279
2346
E000006
ATC
NA
3.4
7.0
33
105
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
7.8
7.0
15
20
5BA08
NOMESCO Finland
NA
14.2
6.9
11
8
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.7
6.9
22
49
WX882
NOMESCO Finland
High dependency care
5.9
6.9
18
32
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
11.3
6.8
12
11
J96.0
ICD-10 Finland
Acute respiratory failure
11.3
6.8
12
11
PJA10
NOMESCO Finland
Exploration of lymph nodes
9.6
6.8
13
14
R60.0
ICD-10 Finland
Localized oedema
3.0
6.8
39
142
D73.1
ICD-10 Finland
Hypersplenism
40.9
6.8
8
*
G72.9
ICD-10 Finland
Myopathy, unspecified
40.9
6.8
8
*
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
17.1
6.8
10
6
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
17.1
6.8
10
6
M05BA07
ATC
risedronic acid; oral
6.7
6.7
16
25
4222
FHL
Endonasal etmoidectomy
23.1
6.7
9
*
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
6.1
6.7
17
29
WX725
NOMESCO Finland
Noninvasive ventilation
3.7
6.7
28
81
ZY010
NOMESCO Finland
Hospital outpatient
3.8
6.7
27
76
C82.1
ICD-10 Finland
Follicular lymphoma grade II
12.6
6.6
11
9
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
6.6
130
847
R13
ICD-10 Finland
Dysphagia
3.4
6.6
30
93
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.3
6.5
32
105
WX872
NOMESCO Finland
Intensive care
4.0
6.5
25
67
UJD02
NOMESCO Finland
Gastroscopy
4.3
6.5
23
57
X58
ICD-10 Finland
Exposure to other specified factors
2.4
6.5
58
272
3XA02
NOMESCO Finland
NA
71.2
6.4
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
71.2
6.4
7
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
6.8
6.4
15
23
L04AA01
ATC
[U] ciclosporin; systemic
6.2
6.4
16
27
ZXH06
SPAT
NA
6.2
6.4
16
27
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.5
6.4
21
49
WX002
NOMESCO Finland
Sedation and analgesia
2.1
6.4
74
394
Z31.5
ICD-10 Finland
Genetic counselling
3.8
6.3
25
69
R04
ICPC
Breathing problem other
5.0
6.3
19
40
L01AA02
ATC
chlorambucil; oral
+∞
6.3
6
*
D81.9
ICD-10 Finland
Combined immunodeficiency, unspecified
+∞
6.3
6
*
J01XB01
ATC
colistin; inhalant, parenteral
+∞
6.3
6
*
132
Kela drug reimbursment
Sarcoidosis
+∞
6.3
6
*
2790B
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI A]
+∞
6.3
6
*
GD1BG
NOMESCO Finland
MRI of lungs and pleura with high intensity magnet
+∞
6.3
6
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.8
6.2
25
70
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.1
6.2
32
109
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
6.2
150
1041
H25.1
ICD-10 Finland
Senile nuclear cataract
2.2
6.2
63
314
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.0
6.2
23
60
R05
ICPC
Cough
2.0
6.2
82
460
N05BA01
ATC
diazepam; systemic, rectal
2.4
6.2
51
229
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.9
6.2
13
17
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.9
6.2
13
17
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.6
6.2
20
46
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
5.1
6.1
18
37
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.0
6.1
23
61
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
12.8
6.1
10
8
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
12.8
6.1
10
8
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
12.8
6.1
10
8
L04AA13
ATC
leflunomide; oral
5.4
6.1
17
33
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.4
6.1
28
88
N06AX21
ATC
duloxetine; oral
2.6
6.1
43
179
M35.7
ICD-10 Finland
Hypermobility syndrome
10.3
6.1
11
11
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
6.0
128
850

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028026) IgM [Mass/volume] in Serum or Plasma
259
205
38.61
300.23
4.9
1.6
g/l
1.1
1.5
1.07
226
191
(3011412) CD3 cells [#/volume] in Blood
147
24
100.10
276.55
2.6
1.6
e9/l
1.2
1.1
—
107
7
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
129
13
150.74
257.68
2.2
1.8
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
126
13
145.46
250.81
2.1
1.8
%
12.7
9.5
—
71
8
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
105
21
69.06
187.79
2.7
1.6
e6/l
528.9
757.8
0.57
91
15
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
103
20
70.62
185.17
2.8
1.6
e9/l
0.2
0.2
0.79
91
15
(4062490)
103
26
54.24
174.79
2.3
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
102
26
53.51
172.62
2.3
1.3
g/l
1.6
2.9
1.88
81
17
(3027135) IgG subclass 1 [Mass/volume] in Serum
101
26
52.80
170.45
2.3
1.3
g/l
4.3
6.9
3.79
81
18
(3024139) IgG subclass 3 [Mass/volume] in Serum
101
26
52.80
170.45
2.3
1.3
g/l
0.2
0.3
1.41
82
18
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
87
15
75.22
159.06
3.1
1.5
u/l
13.9
12.2
0.51
87
15
(3024980) IgG subclass 4 [Mass/volume] in Serum
107
47
31.46
153.17
2.3
2.0
g/l
0.2
0.8
1.61
87
39
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
80
23
43.94
130.18
2.5
1.5
e6/l
583.8
750.5
0.58
29
11
(3023419) Bacteria identified in Sputum by Culture
85
36
30.24
122.32
4.7
2.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
270
693
11.34
119.31
4.7
1.4
g/l
1.3
2.4
14.49
207
431
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
89
63
18.21
101.53
2.6
1.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
140
203
10.41
99.45
1.9
1.2
u/ml
65.4
265.4
1.05
103
187
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
87
63
17.68
97.93
5.6
6.3
iu/ml
623.8
498.1
—
13
9
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
64
23
33.35
96.76
2.6
2.4
%
42.4
45.0
—
24
5
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
86
63
17.42
96.14
2.6
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
60
25
28.38
85.99
4.6
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
128
197
9.35
85.60
3.4
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
147
269
8.34
84.36
4.9
2.3
g/l
0.2
0.2
0.88
141
253
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
85
77
13.98
83.57
3.7
2.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
348
1530
18.70
81.64
23.4
5.6
e9/l
0.6
0.6
0.29
340
1334
(3006315) Basophils [#/volume] in Blood
348
1532
18.66
81.46
23.6
5.7
e9/l
0.0
0.0
0.81
339
1337
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
56
24
27.25
79.28
4.8
2.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
59
29
23.96
79.18
3.5
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
59
29
23.96
79.18
3.5
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
348
1582
17.66
77.10
23.8
5.7
e9/l
2.0
1.9
0.13
343
1408
(3013115) Eosinophils [#/volume] in Blood
348
1587
17.57
76.67
24.2
6.0
e9/l
0.2
0.2
2.04
342
1408
(42870588) Differential panel, method unspecified - Blood
271
971
7.46
76.54
21.3
5.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
222
682
6.53
73.61
9.5
4.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
66
49
16.13
72.57
2.1
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
64
45
16.94
72.47
2.5
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
92
118
10.01
70.47
3.2
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
166
406
6.54
70.05
4.2
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
77
78
12.16
69.95
1.8
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
41
12
38.24
65.27
2.3
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
44
22
22.53
58.20
2.3
2.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
44
22
22.53
58.20
2.3
2.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
44
22
22.53
58.20
2.3
2.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
65
67
11.53
57.99
3.5
1.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
62
8
92.19
56.99
1.6
1.5
e6/l
134.6
—
—
41
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
53
42
14.53
55.77
2.2
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
117
250
6.35
55.61
9.5
4.6
%
0.6
0.7
0.20
52
79
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
51
39
14.98
54.74
1.9
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
110
226
6.47
54.36
8.9
4.5
%
0.5
0.3
0.56
40
56
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
121
281
5.88
52.33
3.6
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
142
394
5.19
49.77
3.6
2.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
107
233
6.03
49.40
9.8
4.8
%
0.1
0.1
0.15
50
69
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
66
86
9.10
49.21
2.9
2.1
ug/l
1.3
1.6
0.12
60
81
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
45
34
14.90
48.49
2.2
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
115
283
5.42
46.07
3.9
1.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
40
27
16.46
45.75
1.8
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
100
223
5.75
44.67
10.0
4.9
%
0.0
0.0
0.80
41
61
(3027945) Reticulocytes/100 erythrocytes in Blood
110
267
5.41
44.66
6.9
2.8
%
2.1
1.8
1.40
105
248
(3000494) Fungus identified in Specimen by Culture
131
369
4.92
44.50
2.4
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
43
35
13.75
44.30
2.3
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
30
11
29.56
44.24
4.2
1.4
—
—
—
0
0
(44790047)
39
28
15.43
43.11
2.4
1.7
—
—
—
0
0
(44790049)
39
28
15.43
43.11
2.4
1.7
—
—
—
0
0
(44806118)
39
28
15.43
43.11
2.4
1.7
—
—
—
0
0
(44790048)
39
28
15.43
43.11
2.4
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
30
12
27.09
42.93
2.7
2.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
90
189
5.95
42.79
5.3
3.0
e9/l
82.5
75.7
0.57
75
144
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
29
11
28.49
42.24
2.7
2.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
29
11
28.49
42.24
2.7
2.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
43
41
11.72
40.04
4.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
43
41
11.72
40.04
4.5
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
43
41
11.72
40.04
4.5
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
43
42
11.43
39.39
4.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
43
42
11.43
39.39
4.5
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
43
42
11.43
39.39
4.5
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
30
15
21.65
39.34
2.7
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
30
15
21.65
39.34
2.7
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
30
15
21.65
39.34
2.7
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
30
15
21.65
39.34
2.7
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
119
340
4.66
39.19
2.9
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
258
1287
4.22
38.47
4.8
2.3
nmol/l
80.4
76.3
1.57
246
1155
(3037692) Legionella sp identified in Specimen by Organism specific culture
27
11
26.37
38.28
1.6
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
174
668
3.99
38.07
3.5
2.0
mg/l
3.3
3.0
1.29
169
575
(3004588) Protein electrophoresis panel - Serum or Plasma
84
184
5.59
37.88
3.3
2.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
62
101
7.16
37.79
2.5
2.3
g/l
1.4
1.5
0.41
55
91
(40758558) Short blood count panel - Blood
186
769
3.81
36.07
18.9
6.8
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
34
0
+∞
36.02
1.2
0.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
118
364
4.27
34.71
3.2
2.2
%
20.6
23.6
1.21
106
318
(40760892) CBC W Ordered Manual Differential panel - Blood
177
725
3.73
34.49
14.8
4.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
44
54
9.10
34.05
1.7
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
44
55
8.93
33.55
1.6
1.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
86
217
4.84
32.62
3.5
2.7
g/l
62.2
67.5
5.97
80
203
(3021589) Normoblasts [#/volume] in Blood
256
1366
3.75
32.34
25.8
8.8
e9/l
0.0
0.0
0.51
238
1116
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
23
11
22.21
30.52
1.8
1.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
259
1427
3.63
30.35
19.2
6.5
mmol/l
1.2
1.2
0.73
233
1211
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
28
0
+∞
29.57
1.3
0.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
241
1292
3.42
29.06
18.7
6.0
mmol/l
1.2
1.2
1.88
234
1183
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
43
62
7.70
29.04
2.4
1.8
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
22
11
21.18
28.62
1.9
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
36
43
9.15
28.34
1.8
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
40
56
7.88
27.68
8.6
3.6
%
53.8
56.7
0.46
40
56
(3012095) Magnesium [Moles/volume] in Serum or Plasma
124
458
3.55
27.33
8.3
3.5
mmol/l
0.8
0.8
0.36
118
431
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
25
18
14.81
27.32
1.1
8.0
u/ml
—
41.7
—
0
7
(3013707) Erythrocyte sedimentation rate by Westergren method
340
2333
5.90
27.15
16.0
3.9
mm/h
13.9
11.0
2.90
334
2156
(3018418) pH of Serum or Plasma
185
882
3.17
26.57
8.4
3.5
ph
7.4
7.4
0.31
38
172
(3048689) Calprotectin [Mass/mass] in Stool
115
415
3.55
26.15
2.7
2.4
ug/g
189.3
116.0
0.93
97
326
(3000492) Spirometry study
97
314
3.82
25.96
3.6
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
92
288
3.91
25.83
4.3
2.0
nmol/l
283.0
368.7
4.06
84
259
(3000570) Elastase.pancreatic [Mass/mass] in Stool
50
96
5.86
25.61
1.6
1.4
ug/g
333.5
289.2
0.78
39
55
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
24
20
12.75
24.07
1.5
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
23
18
13.55
23.92
1.6
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
118
455
3.33
23.90
1.9
1.4
titre
709.6
575.0
0.31
23
104
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
65
167
4.50
23.72
2.2
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
141
610
3.10
23.42
1.9
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
28
31
9.68
23.25
2.5
1.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
95
326
3.56
23.08
17.1
7.0
mmol/l
103.7
104.1
0.35
95
316
(3042631) Mycobacterium sp identified in Specimen
29
34
9.16
23.07
3.3
2.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
19
11
18.14
23.05
1.2
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
201
1067
2.90
22.83
7.5
3.2
u/l
43.0
32.8
0.68
196
1019
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
123
501
3.17
22.56
1.9
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
47
98
5.34
21.94
6.2
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
77
237
3.83
21.92
14.1
3.7
mmol/l
1.7
2.3
0.60
68
190
(3045142) Bone marrow Pathology biopsy report
26
29
9.56
21.44
2.0
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
35
56
6.79
21.40
1.7
2.4
g/l
143.8
132.8
—
9
40
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
18
11
17.14
21.24
2.9
1.8
ug/l
80.5
68.1
0.24
18
11
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
193
1036
2.78
20.95
7.8
3.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
47
103
5.07
20.71
4.6
2.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
45
7.42
20.68
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
45
7.42
20.68
1.6
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
31
45
7.42
20.68
1.4
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
152
729
2.82
20.42
4.2
2.9
ng/l
1415.5
830.0
0.71
144
601
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
39
73
5.85
20.42
1.6
1.5
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
18
12
15.71
20.33
5.3
1.5
umol/l
20.3
32.2
2.14
18
12
(40760888) Immunoglobulin light chains.free panel - Serum
35
60
6.33
20.01
4.2
3.9
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
25
29
9.17
20.00
4.4
3.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
268
1730
2.92
19.87
13.4
4.8
mmol/l
6.8
6.5
0.59
258
1612
(3001122) Ferritin [Mass/volume] in Serum or Plasma
227
1354
2.71
19.53
4.4
2.7
ug/l
195.4
102.8
2.53
221
1254
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
48
6.95
19.50
1.4
1.5
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
23
5
48.79
19.42
1.3
1.0
%
97.2
89.4
—
23
5
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
23
5
48.79
19.42
1.3
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
63
186
3.87
18.91
2.1
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
71
228
3.61
18.84
16.7
8.2
mmol/l
1.3
1.3
0.03
65
218
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
89
333
3.19
18.49
5.0
3.0
umol/l
7.6
7.6
0.01
81
290
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
58
165
3.98
18.32
7.5
3.7
mmol/l
1.9
1.7
0.08
44
124
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
60
176
3.87
18.14
7.7
3.6
kpa
5.2
5.2
0.04
54
166
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
52
6.41
18.07
1.3
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
25
33
8.05
18.04
1.6
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
98
393
3.02
18.03
1.8
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
59
173
3.86
17.84
7.7
3.6
ph
7.4
7.4
—
5
21
(3000991) Gas panel - Venous blood
69
225
3.53
17.84
19.0
9.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
22
25
9.29
17.83
1.7
1.0
u/ml
0.5
0.1
—
13
10
(3019060) Gas panel - Arterial blood
55
154
4.01
17.74
14.7
8.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
39
84
5.07
17.47
1.3
1.2
titre
56.0
56.3
—
5
8
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
38
80
5.17
17.47
4.2
3.4
mg/l
28.0
27.7
0.01
30
65
(3034860) Kappa light chains.free [Mass/volume] in Serum
38
80
5.17
17.47
4.2
3.3
mg/l
30.9
128.6
0.67
30
66
(3000850) Epithelial cells [#/volume] in Urine
126
587
2.73
17.45
5.4
2.4
e6/l
4.4
5.4
0.56
116
518
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
18
16
11.77
17.22
1.9
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
18
16
11.77
17.22
1.9
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
38
7.28
17.19
6.7
3.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
33
62
5.74
17.16
1.4
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
40
90
4.86
17.03
2.9
2.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
19
19
10.48
16.83
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
72
250
3.33
16.82
1.5
1.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
76
280
3.15
16.05
15.7
10.5
kpa
10.7
12.3
2.67
67
270
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
76
280
3.15
16.05
15.7
10.5
kpa
5.0
5.2
0.62
68
269
(3044640) Blood type and Crossmatch panel - Blood
168
929
2.46
16.01
5.0
2.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
36
78
5.00
16.00
4.4
3.4
ratio
3.2
2.7
—
5
11
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
136
683
2.56
15.94
2.9
1.7
mg/l
1.5
1.1
0.30
116
527
(3003396) Base excess in Arterial blood by calculation
76
282
3.13
15.85
15.9
10.5
mmol/l
0.6
1.4
0.63
56
224
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
15
0
+∞
15.73
1.7
0.0
mg/l
2.1
—
—
7
0
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
15
0
+∞
15.73
1.7
0.0
mg/l
0.7
—
—
6
0
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
15
0
+∞
15.73
1.7
0.0
mg/l
0.2
—
—
5
0
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
15
0
+∞
15.73
1.7
0.0
mg/l
5.5
—
—
6
0
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
15
0
+∞
15.73
1.7
0.0
mg/l
0.2
—
—
5
0
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
15
0
+∞
15.73
1.7
0.0
mg/l
0.2
—
—
7
0
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
15
0
+∞
15.73
1.7
0.0
mg/l
0.2
—
—
6
0
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
15
0
+∞
15.73
1.7
0.0
mg/l
0.4
—
—
6
0
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
15
0
+∞
15.73
1.7
0.0
mg/l
0.4
—
—
6
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
15
0
+∞
15.73
1.7
0.0
mg/l
0.6
—
—
6
0
(21494434) Karyotype in Bone marrow
20
24
8.75
15.52
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
72
5.09
15.50
12.3
3.6
u/ml
0.4
0.3
0.16
28
38
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
161
885
2.44
15.41
4.4
2.1
u/l
114.7
237.6
0.98
154
845
(3017704) Immunofixation for Urine
16
14
11.89
15.41
1.5
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
115
544
2.61
15.15
5.7
2.7
mosm/kgh2o
513.0
559.2
1.60
109
465
(3016502) Oxygen saturation in Arterial blood
70
256
3.13
14.91
16.6
10.9
%
95.0
95.9
0.72
62
249
(3015171) Extractable nuclear Ab [Units/volume] in Serum
46
128
3.96
14.90
1.6
1.2
u/ml
2.6
4.5
—
14
6
(4034850)
39
96
4.42
14.85
15.3
11.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
30
59
5.44
14.84
1.4
1.4
u/ml
84.8
110.1
1.10
13
12
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
18
20
9.40
14.77
1.1
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
49
145
3.74
14.54
2.9
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
147
796
2.39
14.34
6.5
2.9
e6/l
0.2
0.5
1.08
128
570
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
18
21
8.95
14.24
1.4
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
19
24
8.29
14.14
2.5
2.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
27
51
5.63
13.93
1.1
1.1
—
—
—
0
0
(4035726)
70
266
3.01
13.91
1.8
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
17
19
9.32
13.87
1.2
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
14
11.12
13.83
2.7
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
22
8.54
13.74
2.7
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
37
93
4.30
13.70
1.8
1.5
iu/ml
0.0
0.0
—
9
17
(3031040) Bacteria [#/volume] in Urine by Automated count
276
1988
2.47
13.48
9.4
4.0
e6/l
273.4
1028.8
—
5
35
(3026008) Bacteria identified in Urine by Culture
151
848
2.31
13.35
5.2
2.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
18
23
8.17
13.26
1.1
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
138
748
2.34
13.23
7.5
2.6
umol/l
333.9
6682.8
3.10
130
659
(3032080) INR in Blood by Coagulation assay
180
1094
2.24
13.08
13.3
7.1
inr
1.2
1.1
0.06
54
333
(3019309) Folate [Moles/volume] in Red Blood Cells
100
472
2.53
13.01
2.0
1.6
nmol/l
1353.9
1168.9
1.23
87
352
(3026389) Candida sp identified in Specimen by Organism specific culture
21
33
6.68
12.96
1.7
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
174
1047
2.23
12.92
7.7
3.4
e6/l
52.3
47.8
0.07
141
716
(36304419) Bacteria [Presence] in Urine
142
788
2.29
12.81
6.4
2.8
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
33
80
4.43
12.78
1.7
1.3
u/ml
2.0
1.0
—
11
6
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
42
122
3.75
12.77
3.6
2.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
103
3.99
12.73
4.0
1.6
g/l
2.9
3.1
0.49
24
86
(3020891) Body temperature
38
103
3.99
12.73
9.6
5.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
13
11
12.21
12.70
9.2
5.5
%
37.7
50.6
0.64
13
11
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
16
9.72
12.62
1.3
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
152
874
2.24
12.53
7.0
2.9
e6/l
32.7
45.8
0.34
132
652
(3008152) Bicarbonate [Moles/volume] in Arterial blood
48
155
3.40
12.45
20.5
10.8
mmol/l
24.7
24.9
0.10
42
146
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
25
7.51
12.37
3.6
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
110
3.84
12.36
3.9
1.6
g/l
2.6
3.9
6.53
24
85
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
110
3.84
12.36
3.9
1.6
g/l
7.2
7.5
0.50
25
89
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
110
3.84
12.36
3.9
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
14
10.35
12.30
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
14
10.35
12.30
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
285
2128
2.41
12.09
8.9
3.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
129
702
2.28
12.06
3.8
2.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
212
1407
2.17
12.01
8.1
4.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
35
94
4.00
11.86
5.2
4.0
g/l
0.5
0.2
1.28
23
42
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
20
33
6.35
11.78
1.5
1.2
u/l
57.7
59.2
0.04
13
22
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
15
9.66
11.72
2.9
1.8
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
24
48
5.27
11.63
1.8
1.3
u/ml
42.6
75.1
—
6
5
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
18
8.64
11.57
2.7
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
111
577
2.31
11.49
1.8
1.7
pmol/l
485.7
440.0
1.08
104
481
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
13
10.32
11.40
1.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
6
25.94
11.22
1.1
3.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
36
103
3.76
11.17
1.8
1.3
u/ml
2.3
2.8
0.18
11
15
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
36
104
3.72
11.02
1.7
1.3
u/ml
1.8
7.1
0.70
12
21
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
37
111
3.59
10.71
1.7
1.3
u/ml
6.4
2.0
—
7
7
(4027681)
14
17
8.52
10.68
1.4
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
31
83
3.98
10.54
1.7
1.2
u/ml
20.5
34.3
—
11
9
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
65
4.40
10.54
1.3
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
12
10.30
10.49
1.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
15
8
19.46
10.34
1.1
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
19
34
5.83
10.33
1.6
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
40
130
3.32
10.24
9.7
3.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
58
234
2.75
10.20
7.4
3.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
174
1128
2.01
9.88
2.5
1.8
pmol/l
94.0
96.6
0.34
118
562
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
16
8.38
9.79
1.8
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
16
8.38
9.79
1.8
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
19
7.62
9.76
4.9
4.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
17
29
6.09
9.68
3.7
2.2
pg
33.8
32.6
0.56
17
29
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
38
124
3.30
9.67
21.2
3.6
mmol/l
24.8
24.6
0.18
30
112
(3021960) Folate [Moles/volume] in Serum or Plasma
115
645
2.13
9.65
2.3
1.4
nmol/l
21.1
21.8
0.20
110
545
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
18
33
5.68
9.54
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
62
4.25
9.40
1.3
1.3
u/ml
233.3
257.1
0.15
18
34
(3029937) Albumin [Presence] in Urine by Test strip
135
817
2.02
9.15
7.3
3.5
estimate
0.0
0.0
0.00
54
281
(3035350) Ketones [Presence] in Urine by Test strip
215
1527
1.96
9.13
6.1
3.3
estimate
0.0
0.0
0.00
50
283
(3048929) Epstein Barr virus Ab [Presence] in Serum
35
113
3.31
9.05
1.3
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
46
175
2.86
9.01
4.1
2.2
ng/l
165.6
128.8
0.24
35
157
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
7
19.17
8.99
5.5
5.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
84
3.66
8.83
1.2
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
82
419
2.22
8.60
1.3
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
22
53
4.35
8.58
1.4
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
101
3.37
8.57
4.2
1.6
g/l
7.8
10.3
2.10
24
92
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
19
7.05
8.49
1.3
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
23
58
4.16
8.46
1.1
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
214
1543
1.90
8.41
7.5
4.5
estimate
0.0
0.0
0.00
54
287
(3017732) Neutrophils [#/volume] in Blood
51
213
2.61
8.35
3.3
2.5
e9/l
3.4
3.9
0.76
35
172
(3009261) Glucose [Presence] in Urine by Test strip
215
1558
1.89
8.26
6.1
3.3
estimate
0.0
0.0
0.50
53
272
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
9
14.90
8.26
1.2
2.1
iu/ml
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
117
694
2.00
8.25
6.4
3.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
62
287
2.39
8.16
2.6
2.4
u/l
31.5
29.0
0.21
56
242
(3008536) Aspergillus sp Ab [Presence] in Serum
12
7
17.66
8.12
1.7
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
20
6.70
8.12
2.7
3.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
20
6.70
8.12
1.5
1.3
e6/l
42892.9
8272.5
—
7
8
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
14
8.06
8.03
3.9
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
14
8.06
8.03
3.9
2.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
31
5.35
8.00
1.2
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
28
85
3.48
7.96
1.3
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
28
86
3.44
7.82
1.6
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
12
8.53
7.61
1.1
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
93
522
2.04
7.58
5.3
3.4
ng/l
89.8
220.5
1.05
70
368
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
160
1079
1.84
7.51
5.9
3.3
ng/l
24.5
32.8
0.63
120
681
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
53
238
2.43
7.44
2.9
2.4
ml/min/173m2
68.1
69.2
0.05
20
101
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
22
6.09
7.43
1.8
1.6
u/l
1.2
3.4
—
6
12
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
7
0
+∞
7.31
1.0
0.0
g/l
0.2
—
—
7
0
(3016018) Differential panel - Cerebral spinal fluid
14
26
5.55
7.30
1.4
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
356
3164
3.47
7.26
55.7
12.2
mg/l
17.3
21.5
3.01
345
2413
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
135
2.84
7.23
23.6
15.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
152
1020
1.82
7.17
6.2
3.3
mmol/l
2.3
2.4
3.39
140
889
(3022145) Colonoscopy Study observation
70
368
2.11
6.74
1.5
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
22
64
3.59
6.67
1.5
1.3
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
6
0
+∞
6.26
1.2
0.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
30
4.81
6.26
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
30
4.81
6.26
1.1
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
34
134
2.69
6.23
11.1
11.7
mmol/l
24.3
24.6
0.18
28
125
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
8
12.80
6.11
1.5
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
31
4.65
6.03
1.1
1.1
—
—
—
0
0
(4015189)
9
6
15.32
5.93
2.3
3.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
83
485
1.91
5.91
5.1
2.5
e6/l
1.1
1.0
0.14
58
249
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
33
4.37
5.60
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
42
3.93
5.59
1.0
1.3
nmol/l
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
55
283
2.11
5.57
4.0
3.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
21
5.37
5.56
1.5
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
47
3.74
5.54
1.2
1.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
0
+∞
5.22
1.4
0.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
162
1196
1.62
4.94
6.7
3.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
81
1225
0.57
4.84
2.8
2.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
42
3.68
4.81
2.1
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
7
11.64
4.80
1.4
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
29
4.24
4.66
1.6
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
16
48
3.44
4.66
1.0
1.3
nmol/l
0.5
0.5
0.20
16
43
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
5
14.23
4.59
1.1
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
11
8.35
4.58
1.0
1.1
miu/ml
1132.8
1749.6
—
9
11
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
11
8.35
4.58
1.0
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
10
21
4.86
4.56
3.1
2.4
%
102.2
94.1
—
10
21
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
8
10.18
4.54
1.1
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
49
3.37
4.52
4.6
3.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
45
3.43
4.37
1.0
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
8
9
9.05
4.30
1.1
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
27
4.17
4.19
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
32
3.84
4.11
1.1
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
72
454
1.73
3.92
6.1
2.7
e6/l
2.6
3.2
0.32
47
223
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
24
4.25
3.91
1.2
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
11
7.40
3.87
1.6
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
257
2186
1.56
3.83
4.6
3.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
39
3.42
3.79
3.9
3.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
99
684
1.61
3.79
7.6
3.4
kg/l
1.0
1.0
—
7
98
(3048879) Bone marrow aspiration report
6
5
12.16
3.77
1.3
3.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
25
4.08
3.72
3.0
2.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
287
3156
0.61
3.70
4.4
4.3
mmol/l
4.7
4.8
1.00
275
2945
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
286
3144
0.62
3.60
4.3
4.2
mmol/l
1.5
1.5
0.81
274
2922
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
328
2980
1.80
3.56
34.5
11.4
ml/min/173m2
85.1
85.2
0.01
309
2410
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
63
2.78
3.54
1.4
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
9
17
5.40
3.53
1.4
1.5
u/field
0.7
1.2
—
9
12
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
107
765
1.56
3.52
1.4
1.3
u/ml
0.8
1.8
0.85
22
212
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
13
6.26
3.52
1.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
31
3.63
3.51
1.7
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
31
3.63
3.51
2.2
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
36
3.41
3.50
2.2
2.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
123
911
1.52
3.43
4.2
3.1
mmol/l
7.0
7.8
1.18
115
777
(4010399)
40
220
1.92
3.39
1.7
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
27
128
2.20
3.39
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
9
18
5.09
3.39
4.1
1.9
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
27
3.78
3.37
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
59
2.79
3.36
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
14
48
2.99
3.33
1.5
1.4
nmol/l
0.3
0.3
—
9
37
(36660697) Celiac disease serology panel - Serum
47
275
1.81
3.30
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
15
54
2.85
3.29
1.9
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
72
2.58
3.26
1.7
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
28
3.64
3.21
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
11
6.46
3.20
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
11
6.46
3.20
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
11
6.46
3.20
2.4
3.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
11
6.46
3.20
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
11
6.46
3.20
1.0
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
50
2.87
3.12
1.2
1.2
u/ml
1.3
1.7
—
6
14
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
34
3.30
3.08
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
113
2.20
3.07
1.7
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
62
401
1.65
3.06
1.4
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
84
586
1.56
3.04
1.3
1.3
u/ml
5.7
10.2
0.68
34
238
(3000012) Reticulocyte production index
7
12
5.92
3.03
2.1
1.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
114
2.18
3.01
1.7
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
149
2.03
2.99
2.3
2.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
5
10.11
2.98
2.8
1.4
umol/l
48.2
36.6
—
5
5
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
5
10.11
2.98
1.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
5
10.11
2.98
2.8
1.8
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
5
10.11
2.98
1.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
5
10.11
2.98
1.0
1.6
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
5
10.11
2.98
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
17
4.78
2.93
3.0
2.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
17
4.78
2.93
1.8
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
22
4.16
2.90
1.6
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
116
2.14
2.90
1.7
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
277
3035
0.67
2.88
4.2
3.8
mmol/l
1.4
1.3
2.21
267
2810
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
84
593
1.54
2.88
1.4
1.3
iu/ml
15.1
35.0
2.87
20
188
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
296
3199
0.65
2.86
4.8
4.7
mmol/l
2.7
2.9
2.39
282
2967
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
24
117
2.12
2.84
1.5
2.3
u/l
5228.0
4465.3
—
8
41
(3045414) Leukocytes [Presence] in Urine
25
124
2.09
2.83
2.4
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
53
2.71
2.82
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
59
2.61
2.82
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
43
259
1.75
2.75
5.5
3.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
6
8.42
2.75
3.2
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
54
2.65
2.73
1.1
1.2
u/ml
2.3
3.8
—
6
23
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
49
307
1.69
2.73
3.4
4.1
ug/l
3.8
6.6
0.90
39
254
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
10
6.08
2.71
2.8
2.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
10
6.08
2.71
1.2
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
49
2.71
2.65
1.5
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
277
2472
1.46
2.65
5.1
3.9
pmol/l
15.1
14.6
2.86
264
2258
(3012516) Albumin [Mass/volume] in Urine
108
816
1.45
2.64
4.6
3.2
mg/l
2303.1
405.5
1.11
66
508
(3013139) Helicobacter pylori Ag [Presence] in Stool
36
210
1.79
2.57
1.2
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
11
5.52
2.55
7.0
4.4
u/l
192.3
214.9
—
6
11
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
222
0.39
2.52
1.2
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
157
1280
1.39
2.48
2.8
2.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
14
57
2.51
2.48
50.1
3.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
316
0.45
2.44
1.2
1.7
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
8
6.32
2.38
1.2
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
8
6.32
2.38
1.0
1.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
31
178
1.81
2.35
1.0
1.1
—
106.0
—
0
5
(4268621)
10
35
2.91
2.32
2.4
2.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
13
4.67
2.28
1.2
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
6
13
4.67
2.28
1.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
89
666
1.44
2.27
1.7
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
54
2.46
2.22
2.1
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
21
380
0.53
2.20
1.2
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
108
2.00
2.20
1.9
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
25
3.25
2.10
1.0
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
47
314
1.57
2.06
1.8
1.7
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
5
11
4.59
1.94
3.0
1.1
umol/l
4.2
7.1
—
5
11
(3019225) pH of Specimen
41
269
1.59
1.94
12.0
4.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
33
2.77
1.94
1.7
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
108
859
1.36
1.91
4.8
4.0
mg/mmol
36.4
10.9
1.16
70
530
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
12
52
2.35
1.89
1.8
1.1
iu/ml
105.2
10.5
—
6
11
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
28
2.90
1.87
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
28
2.90
1.87
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
28
2.90
1.87
1.4
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
6
17
3.57
1.84
1.2
1.2
—
1.1
—
0
5
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
12
4.21
1.83
1.0
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
12
4.21
1.83
1.0
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
35
225
1.61
1.81
1.3
1.3
—
35.8
—
0
11
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
29
2.80
1.80
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
29
2.80
1.80
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
29
2.80
1.80
1.4
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
38
250
1.58
1.79
2.4
2.4
—
9.4
—
0
10
(3028271) Lactate [Moles/volume] in Capillary blood
10
41
2.48
1.77
3.2
1.9
mmol/l
1.4
1.6
—
10
41
(3006653) Thiamine [Moles/volume] in Blood
5
13
3.88
1.72
1.6
1.5
nmol/l
105.6
150.4
—
5
13
(3028707) Methadone [Presence] in Urine by Screen method
15
75
2.04
1.72
1.7
2.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
21
119
1.81
1.70
1.5
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
112
1.83
1.68
1.1
1.4
miu/ml
422.9
247.2
—
8
58
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
120
1.79
1.66
1.5
2.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
7
25
2.83
1.65
1.4
1.7
u/field
0.4
3.1
—
7
11
(3004616) Nuclear Ab [Presence] in Serum
11
49
2.28
1.65
1.2
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
70
532
1.39
1.63
3.7
2.6
mmol/l
2.5
2.4
0.53
62
467
(40761511) CBC panel - Blood by Automated count
349
3344
1.63
1.62
39.8
11.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
106
873
1.30
1.45
5.0
3.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
22
2.75
1.44
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
41
2.22
1.38
1.7
1.6
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
17
2.97
1.36
2.8
2.6
umol/l
23.0
29.5
—
5
11
(1617658) Protocol used for examination of sentinel lymph nodes
0
41
0.00
1.32
0.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
43
2.12
1.31
3.2
1.9
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
8
35
2.31
1.27
2.6
1.6
%
89.8
90.0
—
8
35
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
369
0.65
1.24
2.0
1.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
38
2.13
1.19
1.6
3.0
nmol/l
2.5
3.2
—
8
38
(3001019) Free T4 and TSH panel - Serum or Plasma
11
197
0.55
1.18
2.1
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
17
103
1.68
1.15
2.5
3.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
29
201
1.48
1.14
2.1
2.7
u/ml
55.8
45.6
0.19
29
196
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
26
178
1.49
1.08
1.5
2.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
52
1.95
1.07
1.2
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
198
1.45
1.01
1.7
1.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
35
2.02
1.00
3.0
2.7
mmol/l
4.1
3.9
—
7
35
(3035285) Chloride [Moles/volume] in Venous blood
7
35
2.02
1.00
3.0
2.7
mmol/l
103.1
105.9
—
7
35
(3032773) Endomysium IgG Ab [Titer] in Serum
7
35
2.02
1.00
1.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
230
2138
1.20
0.92
4.8
3.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
28
2.16
0.92
1.0
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
127
0.54
0.90
1.1
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
45
354
1.31
0.88
1.4
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
22
153
1.47
0.88
1.5
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
22
153
1.47
0.88
1.5
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
22
153
1.47
0.88
1.5
2.1
—
—
—
0
0
(4306422)
8
45
1.79
0.84
1.3
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
51
411
1.28
0.84
1.9
1.9
%
1.8
1.4
1.64
45
372
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
306
2934
1.23
0.83
6.1
4.6
mu/l
1.9
1.9
0.68
294
2700
(3009466) Valproate [Moles/volume] in Serum or Plasma
8
46
1.75
0.83
7.9
5.3
umol/l
337.3
359.8
—
8
40
(3015183) Erythrocyte sedimentation rate
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
48
1.68
0.79
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(4281824)
6
34
1.78
0.76
1.5
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
9
54
1.68
0.75
3.6
3.3
mmol/l
6.6
7.2
—
9
54
(3016879) Cocaine [Presence] in Urine
20
143
1.42
0.71
1.5
2.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
58
1.57
0.70
3.4
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
27
1.86
0.68
9.0
18.3
nmol/l
1496.8
1561.4
—
5
27
(3027944) Amphetamines [Presence] in Urine
21
153
1.39
0.68
1.5
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
28
360
0.76
0.68
10.3
6.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
19
136
1.42
0.68
3.4
3.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
380
1.24
0.64
2.0
2.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
30
1.68
0.61
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
35
1.73
0.58
3.3
2.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
8
54
1.49
0.57
1.4
1.5
u/l
35.4
23.8
—
8
45
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
297
3063
0.85
0.57
5.0
4.3
mmol/l
5.9
5.9
0.02
286
2824
(3040151) Glucose [Moles/volume] in Capillary blood
6
36
1.68
0.57
2.8
7.5
mmol/l
6.4
6.3
—
6
29
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
29
231
1.28
0.56
1.7
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
286
2953
0.87
0.53
47.4
13.0
%
39.0
40.5
2.90
215
2239
(40768793) Breast Pathology biopsy report
6
100
0.59
0.52
1.5
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
85
1.43
0.47
2.9
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
48
414
1.18
0.46
2.2
2.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
70
1.44
0.42
3.0
4.3
—
—
—
0
0
(3016750) Collection duration of Urine
0
16
0.00
0.41
0.0
2.8
—
490.1
—
0
9
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
115
1.32
0.39
1.7
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
37
1.36
0.37
2.2
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
9
71
1.27
0.36
1.2
1.6
pmol/l
223.6
234.5
—
9
66
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
30
255
1.19
0.35
1.3
1.2
iu/ml
74.1
147.3
1.10
14
104
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
281
2881
0.90
0.35
6.2
5.3
mmol/mol
39.9
39.2
0.42
269
2692
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
44
1.37
0.34
2.5
2.3
%
13.9
13.2
—
6
44
(3003338) MCHC [Mass/volume]
283
2758
1.11
0.34
55.0
15.7
g/l
330.4
332.7
4.06
283
2742
(3049717) Cytology report of Urine Cyto stain
12
91
1.33
0.34
2.0
2.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
99
0.70
0.31
1.6
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
19
159
1.21
0.27
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
73
0.68
0.26
1.8
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
180
1.18
0.24
1.1
1.0
—
—
—
0
0
(3013512) EKG study
89
839
1.08
0.23
5.1
3.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
146
0.82
0.22
2.8
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
1.8
—
0
10
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
64
602
1.08
0.18
1.7
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
62
1.13
0.17
1.4
2.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
82
1.23
0.17
1.7
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
53
565
0.93
0.16
4.3
4.1
%
18.7
21.8
0.92
31
246
(3003694) ABO and Rh group [Type] in Blood
80
839
0.94
0.16
1.6
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
21
195
1.08
0.08
4.0
2.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
82
0.85
0.07
1.7
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
85
864
0.98
0.04
1.5
1.6
mmol/l
1.3
1.4
0.40
77
736
(1002224) Polysomnography panel
15
159
0.94
0.03
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
41
418
0.98
0.01
2.8
2.8
ug/l
0.7
0.7
0.02
33
255
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
126
0.95
0.00
2.7
1.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
356
3559
1.01
0.00
68.3
18.3
g/l
130.0
136.4
11.64
356
3504
(3035941) MCH [Entitic mass]
356
3555
1.03
0.00
67.5
18.1
pg
30.0
30.3
1.87
356
3502
(3024731) MCV [Entitic volume]
356
3555
1.03
0.00
67.6
18.1
fl
90.6
90.8
0.19
356
3502
(3051593) INR in Capillary blood by Coagulation assay
0
9
0.00
0.00
0.0
16.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
22.8
—
0
9
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
66
0.91
0.00
1.5
1.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
75
0.93
0.00
1.4
1.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
75
0.93
0.00
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
64
0.94
0.00
1.5
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
64
0.94
0.00
1.5
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
76
0.92
0.00
1.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
75
0.93
0.00
1.4
1.5
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
55
0.91
0.00
1.6
1.5
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
10.4
—
0
5
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
50
1.00
0.00
1.6
1.5
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
6.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
75
0.93
0.00
1.4
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
4.0
—
215.8
—
0
6
(4133840)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_NONHEREDHYPOGAMMA and mortality.

Females

Parameter HR [95% CI] p-value
D3_NONHEREDHYPOGAMMA 3.869 [3.03, 4.95] < 0.001
Birth year 0.991 [0.98, 1.0] 0.063

During the follow-up period (1.1.1998 — 31.12.2019), 147 out of 714 females with D3_NONHEREDHYPOGAMMA died.

Males

Parameter HR [95% CI] p-value
D3_NONHEREDHYPOGAMMA 3.065 [2.24, 4.19] < 0.001
Birth year 0.987 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 99 out of 457 males with D3_NONHEREDHYPOGAMMA died.

Mortality risk

Mortality risk for people of age

years, who have D3_NONHEREDHYPOGAMMA.

N-year risk Females Males
1 0.361% 0.457%
5 2.14% 3.087%
10 5.093% 8.232%
15 9.046% 16.041%
20 15.845% 25.789%

Relationships between endpoints

↥

Index endpoint: D3_NONHEREDHYPOGAMMA – Nonhereditary hypogammaglobulinemia

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data